Associate Director, Regulatory CMC jobs in United States
info-icon
This job has closed.
company-logo

Solid Biosciences · 1 week ago

Associate Director, Regulatory CMC

Solid Biosciences is a precision genetic medicine company focused on advancing gene therapy candidates for rare diseases. The Associate Director of Regulatory CMC will lead regulatory CMC efforts for gene therapy drug development, engage with regulatory agencies, and collaborate with cross-functional teams to ensure compliance and strategic progress of programs.

BiotechnologyGeneticsHealth CareMedical
check
Comp. & Benefits

Responsibilities

Actively represent Regulatory CMC on interdisciplinary teams (e.g. CMC Teams, Program Teams) and with business partners such as consultants, CDMOs etc
Collaborate with cross-functional teams to generate and refine the product development strategy
Lead CMC content for global clinical trial applications including the preparation of INDs/CTAs/GMOs and amendments, responses to agency questions, and maintenance activities. Prepare for later stage submission activities
Interface with CMC and quality teams, including execution of change management and data integrity processes
Drive and contribute to regulatory CMC content and submissions, including necessary cross functional teams and timelines, relevant to assigned projects or programs
Actively contribute to the preparation and execution of global agency meetings
Support development and implementation of global regulatory CMC strategies, including identifying regulatory risks, to facilitate the progress of programs through all phases of development
Represent Solid Bio Regulatory through participation in pharmaceutical trade groups and meetings

Qualification

Regulatory affairsCMC developmentGene therapy experienceIND submissionsChange managementUSEU regulationsCommunicationOrganizational skillsCreative problem solvingCollaboration

Required

Bachelor's degree in a scientific discipline
Minimum of 4 years of experience in regulatory affairs in the pharmaceutical/biotech, including IND activity, global CTAs, BLAs/MAAs and Agency briefing documents in US and ex-US
Knowledge of recombinant manufacturing processes and controls required, with preference for mammalian culture processes
Strong knowledge of US and EU regulations and Guidances pertaining to the CMC aspects of biological product development
Experience in submission management and change management required
Ability to effectively organize and prioritize tasks to achieve established deadlines
Ability to work both independently and within project teams, committees, etc. to achieve group goals, including face to face and remote interactions
Excellent verbal and written communication skills
Ability to author and edit CMC content
Excellent organizational and program management skills that ensure timely completion of objectives by appropriate prioritization, scheduling and assignment of tasks
Strong collaborator with multi-disciplinary teams
Creative problem solving and strategizing abilities

Preferred

Masters, PharmD, or PhD preferred
Experience in gene therapy programs (rAAV) and rare disease programs a plus, although not required

Benefits

Competitive Health and Dental programs with flexible plan offerings, including FSA and HSA programs
401(k) program participation with competitive company matched contributions
Eligibility to participate in Solid’s Employee Stock Purchase Plan
Mobile phone subsidy for eligible employees
Tuition Reimbursement
Vision Coverage
Life Insurance
Voluntary Pet Insurance
Employee Discount Program on Travel, Entertainment, and Services
Daily Subsidized Lunch Delivery (onsite @ Hood Park)
Free Onsite Full-Service Gym (onsite @ Hood Park)
Employee Parking (onsite @ Hood Park)

Company

Solid Biosciences

twittertwittertwitter
company-logo
Solid Biosciences is a life science company that conducts research for the treatment of Duchenne muscular dystrophy.

Funding

Current Stage
Public Company
Total Funding
$810.3M
Key Investors
Ultragenyx PharmaceuticalPerceptive AdvisorsJP Morgan
2025-02-18Post Ipo Equity· $200M
2024-01-08Post Ipo Equity· $109M
2022-09-30Post Ipo Equity· $75M

Leadership Team

leader-logo
Alexander Cumbo
CEO and President
linkedin
leader-logo
Kevin Tan
Chief Financial Officer
linkedin
Company data provided by crunchbase